The 2026 solar eclipse's path of totality crosses over the Arctic and Atlantic Oceans, making these cruises tailored to the ...

HX Expeditions is inviting travellers, and the agents who inspire them, to look ahead to the most exciting chapter yet in ...

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Evening entertainment was a highlight of my northern Europe cruise with varied styles of live music and singers. Service was prompt and friendly. Ship had an interesting layout of public rooms and was ...

Cruise on 25 October 2025 was excellent and o board service and food were great. The joy was marred by gestapo-type parking attendants at the Ocean Cruise Terminal on Southampton. They couldn't read ...